Cost benefit of investment on quality in pharmaceutical manufacturing: WHO GMP pre- and post-certification of a Nigerian pharmaceutical manufacturer

• Príomhchruthaitheoirí: Chimezie Anyakora (Údar), Obinna Ekwunife (Údar), Faith Alozie (Údar), Mopa Esuga (Údar), Jonathan Ukwuru (Údar), Steve Onya (Údar), Jude Nwokike (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: BMC, 2017-09-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Abstract Background Pharmaceutical companies in Africa need to invest in both facilities and quality management systems to achieve good manufacturing practice (GMP) compliance. Compliance to international GMP standards is important to the attainment of World Health Organization (WHO) prequalificatio...